表紙
市場調查報告書
商品編碼
1028941

癌症疫苗的全球市場:COVID-19的成長及變化預測 (∼2030年)

Cancer Vaccines Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球癌症疫苗的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,類型·技術·癌症區分·終端用戶·地區/主要國家等各種區分的明細,競爭環境,主要企業的簡介,未來展望等資料。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢·市場策略

第4章 COVID-19的影響

第5章 市場規模·成長預測

  • 市場規模的轉變·預測
  • 市場成長的促進因素
  • 市場阻礙成長要素

第6章 市場分析·預測:各種區分

  • 各類型
    • 預防用癌症疫苗
    • 治療用癌症疫苗
  • 各技術
    • 樹突狀細胞(DC)癌症疫苗
    • 重組癌症疫苗
    • 抗原/佐劑癌症疫苗
    • 全細胞癌症疫苗
    • 病毒載體·DNA癌症疫苗
  • 癌症各種類
    • 前列腺癌
    • 子宮頸癌
    • 大腸癌
    • 咽喉癌
    • 其他
  • 各終端用戶
    • 癌症治療中心
    • 研究機關

第7章 市場分析·預測:各地各國

第8章 亞太地區市場分析·預測

  • 市場概要
  • 地區資訊·COVID-19的影響·市場資訊·背景資訊·政府措施·法律規章·機關&協會·租稅·投資·主要企業
  • 市場分析·預測:各類型
  • 市場分析·預測:各技術

第9章 中國市場分析·預測

第10章 印度市場分析·預測

第11章 日本市場分析·預測

第12章 澳洲市場分析·預測

第13章 印尼市場分析·預測

第14章 韓國市場分析·預測

第15章 西歐市場分析·預測

第16章 英國市場分析·預測

第17章 德國市場分析·預測

第18章 法國市場分析·預測

第19章 東歐市場分析·預測

第20章 俄羅斯市場分析·預測

第21章 北美市場分析·預測

第22章 美國市場分析·預測

第23章 南美市場分析·預測

第24章 巴西市場分析·預測

第25章 中東市場分析·預測

第26章 非洲市場分析·預測

第27章 競爭情形·企業簡介

  • 競爭情形
  • 企業簡介
    • GlaxoSmithKline
    • Merck
    • Aduro Biotech
    • Astrazeneca Plc
    • Dendreon

第28章 癌症疫苗的開發平台分析

第28章 主要M&A

第29章 未來展望·潛在性分析

第30章 附錄

目錄
Product Code: h966

Cancer Vaccines Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cancer vaccines market.

This report focuses on cancer vaccines market which is experiencing strong growth. The report gives a guide to the cancer vaccines market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cancer vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cancer Vaccines market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cancer vaccines market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer vaccines market section of the report gives context. It compares the cancer vaccines market with other segments of the cancer vaccines market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer vaccines indicators comparison.

Scope

Markets Covered: 1) By Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines; Recombinant Cancer Vaccines; Antigen/Adjuvant Cancer Vaccines; Whole Cell Cancer Vaccines; Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate; Cervical; Colorectal; Throat; Others

4) By End-User: Cancer Treatment Centers; Research Institutes

Companies Mentioned: GlaxoSmithKline; Merck; Aduro Biotech; Astrazeneca Plc; Dendreon

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cancer Vaccines Market Characteristics

3. Cancer Vaccines Market Trends And Strategies

4. Impact Of COVID-19 On Cancer Vaccines

5. Cancer Vaccines Market Size And Growth

  • 5.1. Global Cancer Vaccines Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cancer Vaccines Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cancer Vaccines Market Segmentation

  • 6.1. Global Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines
  • 6.2. Global Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Dendritic Cells (DC) Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector & DNA Cancer Vaccines
  • 6.3. Global Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prostate
  • Cervical
  • Colorectal
  • Throat
  • Others
  • 6.4. Global Cancer Vaccines Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer Treatment Centers
  • Research Institutes

7. Cancer Vaccines Market Regional And Country Analysis

  • 7.1. Global Cancer Vaccines Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Cancer Vaccines Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cancer Vaccines Market

  • 8.1. Asia-Pacific Cancer Vaccines Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cancer Vaccines Market

  • 9.1. China Cancer Vaccines Market Overview
  • 9.2. China Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cancer Vaccines Market

  • 10.1. India Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cancer Vaccines Market

  • 11.1. Japan Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cancer Vaccines Market

  • 12.1. Australia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cancer Vaccines Market

  • 13.1. Indonesia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cancer Vaccines Market

  • 14.1. South Korea Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cancer Vaccines Market

  • 15.1. Western Europe Cancer Vaccines Market Overview
  • 15.2. Western Europe Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cancer Vaccines Market

  • 16.1. UK Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cancer Vaccines Market

  • 17.1. Germany Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cancer Vaccines Market

  • 18.4. France Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cancer Vaccines Market

  • 19.1. Eastern Europe Cancer Vaccines Market Overview
  • 19.2. Eastern Europe Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cancer Vaccines Market

  • 20.1. Russia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cancer Vaccines Market

  • 21.1. North America Cancer Vaccines Market Overview
  • 21.2. North America Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cancer Vaccines Market

  • 22.1. USA Cancer Vaccines Market Overview
  • 22.2. USA Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cancer Vaccines Market

  • 23.1. South America Cancer Vaccines Market Overview
  • 23.2. South America Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cancer Vaccines Market

  • 24.1. Brazil Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cancer Vaccines Market

  • 25.1. Middle East Cancer Vaccines Market Overview
  • 25.2. Middle East Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cancer Vaccines Market

  • 26.1. Africa Cancer Vaccines Market Overview
  • 26.2. Africa Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cancer Vaccines Market Competitive Landscape And Company Profiles

  • 27.1. Cancer Vaccines Market Competitive Landscape
  • 27.2. Cancer Vaccines Market Company Profiles
    • 27.2.1. GlaxoSmithKline
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Aduro Biotech
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Astrazeneca Plc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Dendreon
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Cancer Vaccines Pipeline Analysis

29. Key Mergers And Acquisitions In The Cancer Vaccines Market

30. Cancer Vaccines Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer